XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Recalling firm: Atlantic Pro Nutrients, Inc. dba XYMOGEN
Why it was recalled
Undeclared Soy and Milk on the label.
The exact product
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
All SKUs
Recall details
- Recall number
- F-1523-2013
- Event ID
- 65128
- FDA status
- Terminated
- Initiated
- May 1, 2013
- Reported
- Jun 19, 2013
- Classified
- Jun 11, 2013
- Terminated
- Jan 15, 2014
- Quantity
- 16,268 units
- Location
- Orlando, FL, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.